CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®), a leading resource for continuing medical education, will host the 2nd Annual Precision Medicine Symposium: An Illustrated Tumor Board. The dynamic symposium will take place April 17-18 at InterContinental New York Barclay in New York City and will be chaired by Andre H. Goy, M.D., chairman, executive director, and lymphoma division chief at John Theurer Cancer Center at Hackensack University Medical Center; and chief science officer and director of research and innovation at Regional Cancer Care Associates in Hackensack.
“We look forward to hosting our precision medicine conference for the second year in a row,” said Phil Talamo, president of PER®. “This meeting is designed to take a targeted approach to treatment, focusing on how biomarkers and testing strategies can personalize care to patients, often times in a tumor agnostic setting.”
Across a two-day, pan-tumor symposium, expert faculty will cover the latest topics in solid and liquid tumors, including lung, breast, gastrointestinal, genitourinary, skin cancers and hematologic malignancies. The educational meeting will feature high-impact sessions and keynote lectures that will focus on practical takeaways regarding the latest updates in next-generation sequencing, liquid biopsy and cytogenetic testing. The program will review updates in targeted treatment, including tumor-agnostic indications based solely on genomic markers and other biomarkers. The tumor board overall will emphasize the role of advanced genetic panel testing and the use of targeted therapies, with a focus on data that is most relevant to patient care.
For more information and to register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.
